Decentralized clinical trials (DCTs) have gained long-standing interest, yet their adoption as a new paradigm remains uncertain even with broader acceptance from regulatory and industry. This study aims to unveil its evolutional trend, which…
Continue Reading
Microsoft has made a revolutionary leap in artificial intelligence healthcare technology, with CEO Mustafa Suleyman declaring that the tech giant has taken “a genuine step toward medical superintelligence.” This groundbreaking development represents a significant…
Continue Reading
Accelerating Clinical Trials Through Automation and AI
The recruitment phase for clinical trials takes an average of 18 months, and nearly 20% of cancer trials fail because of low accrual rates. Automation and AI can…
What You Should Know:
– ForSight Robotics, the pioneer in ophthalmic robotic surgery secures $125M Series B round, led by Eclipse.
– The investment will accelerate the next growth phase for the ORYOM™ Platform, the world’s…
Continue Reading
Natalie Schibell, VP of Market Strategy and Communications at Aetion,
Real-world evidence (RWE) has become central to evaluating therapies, medical products, and health interventions—providing insight into how they perform outside controlled clinical trials. As healthcare…
Continue Reading
Patients will be able to browse and sign up to clinical trials via the NHS App, the Department of Health and Care (DHSC) has announced.
Eventually the app will be able to automatically match…
The recent wave of National Institutes of Health (NIH) grant terminations has created an unprecedented crisis in American medical research, stripping nearly $2 billion in critical funding from U.S. medical schools and hospitals. This…
Continue Reading
The American healthcare system faces an unprecedented crisis as proposed changes to federal health institutions create what the Association of American Medical Colleges (AAMC) calls “an existential threat” to biomedical research, medical schools, and…
Continue Reading
Viraj Narayanan, CEO at Cornerstone AI
Daniel Lane, Head of RWD Strategy & Operations at Bristol Myers Squibb
Real-world data (RWD) has become the pharmaceutical industry’s most promising yet challenging frontier. While companies have long…
Continue Reading
The Problem with Traditional Mental Health Assessment
Neuroscience technology company Brooklyn Health is leveraging artificial intelligence to address a critical flaw in neurology and psychiatry: the unreliable approach to mental health outcomes measurement. The startup’s…
